Related Topics News -

     
 < Previous page   Detail   |   Print 
     
《大行》匯研上調藥明康德目標價至162.5元 維持「買入」評級
2026-04-30T  
《大行》招銀國際升藥明康德目標價至143元人幣 評級「買入」
2026-04-29T  
《大行》高盛升藥明康德目標價至169.4港元 業務增長具韌性
2026-04-29T  
《大行》摩通上調藥明康德目標價至172元 維持「增持」評級
2026-04-29T  
《大行》高盛:藥明康德今年首季業績遠勝預期 維持「買入」評級
2026-04-28T  
《輪動華泰》寧德大手配股籌50億美元 建滔基層板再創新高
2026-04-28T  
《績後》一文綜合大行於藥明康德公布季績後最新目標價及觀點
2026-04-28T  
《大行》里昂:藥明康德首季表現強勁 列行業首選股
2026-04-28T  
《大行》大摩料藥明康德股價未來30日上升
2026-04-28T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.